STOCK TITAN

Doximity, Inc. - DOCS STOCK NEWS

Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.

Doximity, Inc. (symbol: DOCS) is a leading digital platform designed specifically for U.S. medical professionals. The company connects over a million healthcare professionals, including more than 70% of U.S. physicians and 45% of nurse practitioners and physician assistants, making it the largest HIPAA-secure medical network in the country.

Founded to enhance the productivity and success of medical professionals, Doximity offers a cloud-based platform that provides members with specialized tools for collaboration, secure patient care coordination, virtual patient visits, career management, and staying informed with the latest medical news and research. Available on the web, iPhone, iPad, Apple Watch, and Android devices, Doximity ensures accessibility and convenience for its users.

In recent years, Doximity has achieved significant milestones, including expanding its user base and enhancing its platform capabilities. The company continues to innovate and form strategic partnerships to deliver valuable services to the medical community.

With a commitment to supporting healthcare professionals in a system increasingly run by executives, Doximity ensures that those who take care of us are well-equipped to succeed in their roles. The company's financial condition remains robust, driven by its growing member base and continuous development of its platform.

For the latest updates on Doximity, including recent achievements and ongoing projects, refer to the news section below.

  • Latest News: Source: Doximity
  • ---
  • ---
  • ---
  • ---
  • ---
  • ---
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) reported total revenues of $115.3 million for Q3 fiscal 2023, reflecting an 18% increase year-over-year. Operating cash flow reached $48.7 million, up 78%, while free cash flow surged to $47.5 million, marking an 85% growth. However, net income decreased to $33.5 million from $55.6 million, resulting in a net income margin of 29%. For Q4, the company forecasts revenue of $109.6 million to $110.6 million and maintains a positive outlook for FY 2024, projecting revenues over $500 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.88%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE:DOCS) announced it will report its fiscal third-quarter financial results for the period ending December 31, 2022 on February 9, 2023, after market close. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results in detail. Doximity is recognized as the leading digital platform connecting over 80% of U.S. physicians across various specialties, offering tools that enhance productivity and patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.12%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) has announced that CFO Anna Bryson will participate in a fireside chat at the Raymond James Technology Investor Conference on December 5, 2022, at 10:20 a.m. Eastern Time. Doximity is a leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians as members. The platform offers various digital tools to enhance productivity, allowing members to collaborate, stay updated on medical news, manage careers, and conduct virtual patient visits. Visit www.doximity.com for more information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) reported Q2 2023 total revenues of $102.2 million, a 29% year-over-year increase. Operating cash flow rose to $39.5 million (+106%), with free cash flow reaching $37.7 million (+109%). Net income fell to $26.3 million (margin of 26%) compared to the previous year, while non-GAAP net income was $36.2 million (35% margin). Doximity projects Q3 2023 revenue between $110.7 million and $111.7 million, affirming full-year revenue guidance of $424.0 million to $432.0 million. A $70 million stock repurchase program was also authorized.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.7%
Tags
-
Rhea-AI Summary

Doximity, Inc. (NYSE:DOCS) announced it will report its financial results for the second quarter ending September 30, 2022, after market close on November 10, 2022. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% membership among U.S. physicians across all specialties, providing tools for collaboration, career management, and virtual patient visits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
-
Rhea-AI Summary

Salvo Health has launched a virtual health clinic aimed at addressing chronic gut conditions for over 60 million Americans. The company recently secured $10.5 million in seed funding led by Threshold Ventures, along with Torch Capital and Felicis. Salvo Health offers a comprehensive care model, Whole Self Science, that integrates various health disciplines to provide personalized treatment plans. Their approach includes unlimited access to a dedicated care team, emphasizing root cause treatment over conventional methods. The company plans to expand its services across the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.15%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.44%
Tags
none
-
Rhea-AI Summary

Doximity (NYSE: DOCS) recently appointed Phoebe L. Yang to its Board of Directors. Ms. Yang brings extensive health system and cloud expertise, having held key roles at Amazon Web Services and CommonSpirit Health. She was recognized as one of Modern Healthcare's Top 100 Most Influential People in Healthcare. Doximity CEO Jeff Tangney emphasized her dual expertise in healthcare and technology as pivotal for the company's growth and innovation in clinical tools. Yang expressed enthusiasm about contributing to Doximity's mission of enhancing physician productivity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.44%
Tags
management
-
Rhea-AI Summary

Doximity reported Q1 fiscal 2023 revenues of $90.6 million, a 25% increase year-over-year, alongside an operating cash flow of $44.8 million, up 35%. The net income of $22.4 million marked a decrease from the previous year's $26.3 million, leading to a margin drop from 36% to 25%. The company maintains a positive outlook, projecting Q2 revenue between $99.5 million and $100.5 million and adjusting full-year revenue guidance to between $424.0 million and $432.0 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.44%
Tags
Rhea-AI Summary

Doximity, Inc. (NYSE: DOCS) will report its first-quarter financial results for the period ending June 30, 2022, after market close on August 4, 2022. A conference call to discuss these results will take place at 2:00 p.m. PT (5:00 p.m. ET). Doximity, founded in 2010, is the leading digital platform for U.S. medical professionals, encompassing over 80% of physicians across various specialties. The platform offers tools for collaboration, medical news updates, career management, and virtual patient visits, aiming to enhance productivity in healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.21%
Tags

FAQ

What is the current stock price of Doximity (DOCS)?

The current stock price of Doximity (DOCS) is $57.83 as of December 20, 2024.

What is the market cap of Doximity (DOCS)?

The market cap of Doximity (DOCS) is approximately 10.3B.

What is Doximity, Inc.?

Doximity, Inc. (DOCS) is a digital platform that connects over a million healthcare professionals in the U.S., offering tools for collaboration, secure patient care coordination, virtual visits, and career management.

Who are the primary users of Doximity?

The primary users of Doximity include over 70% of U.S. physicians, 45% of nurse practitioners, and physician assistants, making it the largest HIPAA-secure medical network in the country.

What services does Doximity provide?

Doximity offers a cloud-based platform that includes tools for professional collaboration, secure patient care coordination, virtual patient visits, staying updated with medical news and research, and managing medical careers.

Is Doximity accessible on multiple devices?

Yes, Doximity is available on the web, iPhone, iPad, Apple Watch, and Android devices, ensuring accessibility and convenience for its users.

How does Doximity support healthcare professionals?

Doximity supports healthcare professionals by providing specialized tools for collaboration, patient care coordination, virtual visits, career management, and access to the latest medical news and research.

What recent achievements has Doximity made?

Doximity has expanded its user base, enhanced its platform capabilities, and formed strategic partnerships to deliver valuable services to the medical community.

How does Doximity ensure data security?

Doximity is the largest HIPAA-secure medical network in the U.S., ensuring the security and confidentiality of patient and professional data.

Can patients use Doximity?

While Doximity is designed for medical professionals, it includes features like secure patient care coordination and virtual visits which benefit patients indirectly.

Is Doximity free to use?

Yes, Doximity is available for free on the web, iPhone, iPad, Apple Watch, and Android devices.

Where can I find the latest news about Doximity?

The latest news and updates about Doximity can be found in the news section of their website or on stock market websites like StockTitan.

Doximity, Inc.

NYSE:DOCS

DOCS Rankings

DOCS Stock Data

10.26B
124.59M
2.72%
93.1%
4.67%
Health Information Services
Services-computer Programming Services
Link
United States of America
SAN FRANCISCO